.STUDY EMPHASIZE.06 August 2024.
A huge randomized controlled trial along with cisgender ladies highlights the obstacles of adherence to a regular dental preexposure prevention program as well as illustrates that twice-yearly treatment of lenacapavir can preserve successful HIV prevention amounts over 6 months.